Pharmacokinetics of a Standard Paracetamol Tablet and Oral Solution After Oral Administration in Chinese Healthy Volunteers
NCT02095704 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2014-03-26
Summary
Drug dissolution in vivo play a crucial role for the bioavailability and therapeutic of an orally administered solid dosage form. The aim of this study was to evaluate the pharmacokinetics of a standard paracetamol tablet in comparison with oral solution in Chinese healthy volunteers. Based on the Noyes-Whitney equation and pharmacokinetics parameters, investigators trend to propose a method to estimate in vivo dissolution time and dissolution kinetics of solid dosage form.
Conditions
- Focus of Study: Pharmacokinetics Analysis, in Vivo Dissolution Studies
Interventions
- DRUG
-
paracetamol oral solution
dosage form: paracetamol oral solution;dosage:15.6ml(containing 500 mg of the active ingredient);frequency:single dose
- DRUG
-
paracetamol tablet
dosage form: paracetamol tablet;dosage: 500 mg;frequency:single dose
Sponsors & Collaborators
-
Central South University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 25 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
More Related Trials
-
Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects
NCT05711797 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet
NCT01125670 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers
NCT02533102 ·Status: COMPLETED ·Phase: PHASE1
-
INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function
NCT02474537 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers
NCT04692025 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
NCT01267071 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function
NCT05126329 ·Status: TERMINATED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects
NCT02557789 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032
NCT01019070 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers
NCT02374437 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Paracetamol in Patients Over 80 Years Hospitalized to an Acute Geriatric Ward
NCT03617471 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04249284 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
NCT00359177 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis
NCT02182167 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
NCT03702673 ·Status: COMPLETED ·Phase: PHASE1
-
CP-690,550 Pharmacokinetics In Healthy Chinese Subjects
NCT01101919 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy Subjects
NCT07024888 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects
NCT04654897 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
NCT03500627 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment
NCT04859426 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
NCT01359462 ·Status: COMPLETED ·Phase: PHASE1
-
A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants
NCT02541669 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition
NCT04640571 ·Status: COMPLETED ·Phase: PHASE4
-
The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects
NCT04686825 ·Status: COMPLETED ·Phase: PHASE1